These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8999570)

  • 1. [Neurofibromatosis type I in Norway. A clinical prevalence study based on a small project].
    Bjłrnstad A; Heiberg A
    Tidsskr Nor Laegeforen; 1996 Oct; 116(26):3108-10. PubMed ID: 8999570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurofibromatosis type 1 in childhood].
    Kongshaug N; Meyer B; Kolmannskog S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(18):2653-7. PubMed ID: 10479978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health supervision for children with neurofibromatosis.
    Hersh JH;
    Pediatrics; 2008 Mar; 121(3):633-42. PubMed ID: 18310216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lisch nodules. Markers for a non-invasive diagnosis in Recklinghausen neurofibromatosis].
    Crişan M; Talu S; Florea M; Coprean D; Cosgarea R; Crişan D
    Oftalmologia; 2008; 52(4):56-61. PubMed ID: 19354164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis].
    Wolkenstein P; Decq P
    Neurochirurgie; 1998 Nov; 44(4):267-72. PubMed ID: 9864698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment.
    Lammert M; Friedman JM; Kluwe L; Mautner VF
    Arch Dermatol; 2005 Jan; 141(1):71-4. PubMed ID: 15655144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurofibromatosis type 1 in children].
    Lund AM; Skovby F
    Ugeskr Laeger; 1994 May; 156(21):3180-2. PubMed ID: 8066837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurofibromatosis in children. Our experience].
    López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
    Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis type 1: update on a common genetic condition.
    Siqveland E; Pond D
    Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of neurofibromatosis type 1].
    Lozada Y; Alvarez-Valiente H; Argüelles M
    Rev Neurol; 1998 Nov; 27(159):792-5. PubMed ID: 9859153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing neurofibromatosis type I in children.
    Davis RE
    Nurse Pract; 1997 Apr; 22(4):73-6, 79-81. PubMed ID: 9128879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
    Odebode TO; Afolayan EA; Adigun IA; Daramola OO
    Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurofibromatosis type 1: a multidisciplinary approach to care.
    Hirbe AC; Gutmann DH
    Lancet Neurol; 2014 Aug; 13(8):834-43. PubMed ID: 25030515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study.
    Erichsen AK; Koht J; Stray-Pedersen A; Abdelnoor M; Tallaksen CM
    Brain; 2009 Jun; 132(Pt 6):1577-88. PubMed ID: 19339254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early grade repetition and inattention associated with neurofibromatosis type 1.
    Coudé FX; Mignot C; Lyonnet S; Munnich A
    J Atten Disord; 2007 Sep; 11(2):101-5. PubMed ID: 17494836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children.
    Coudé FX; Mignot C; Lyonnet S; Munnich A
    Behav Genet; 2006 Sep; 36(5):660-4. PubMed ID: 16474913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.